• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锂的安全性概况:使用美国食品药品监督管理局不良事件报告系统的不成比例性分析

Safety Profile of Lithium: A Disproportionality Analysis Using the FDA Adverse Event Reporting System.

作者信息

Zhu Hao, Guo Jack, Lui Hannah, Ip Patrick

机构信息

Department of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong, China,

Department of Health and Kinesiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

出版信息

Neuropsychobiology. 2025 May 30:1-9. doi: 10.1159/000546602.

DOI:10.1159/000546602
PMID:40451179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12215163/
Abstract

INTRODUCTION

Although lithium has long been considered the gold standard for mood stabilization in the treatment of bipolar disorder, growing concerns about its adverse events have significantly undermined its once-trusted status. This study aims to conduct a pharmacovigilance analysis of lithium to provide a more comprehensive understanding of its safety profile.

METHODS

Four disproportionality analysis methods, including reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and empirical Bayes geometric mean (EBGM), were employed to detect potential signals between lithium and various adverse events.

RESULTS

Analysis of 6,909 adverse event reports from the FDA Adverse Event Reporting System (FAERS) showed that lithium-related adverse events occur in the endocrine, renal or urinary, nervous, and psychiatric systems. Well-known adverse events, such as hypothyroidism, nephrogenic diabetes insipidus, and ataxia, were found. In addition, several previously overlooked adverse events, such as renal oncocytoma, benign parathyroid tumor, and Adams-Stokes syndrome, were identified.

CONCLUSION

By analyzing real-world data, this study provides a comprehensive evaluation of lithium's safety profile, offering critical evidence for its clinical risk. However, given the inherent limitations of FAERS, such as underreporting of minor symptoms, the findings should be interpreted cautiously.

摘要

引言

尽管长期以来锂盐一直被视为治疗双相情感障碍时情绪稳定的金标准,但对其不良事件的日益担忧已严重损害了它曾经备受信任的地位。本研究旨在对锂盐进行药物警戒分析,以更全面地了解其安全性概况。

方法

采用四种不成比例分析方法,包括报告比值比(ROR)、比例报告比(PRR)、贝叶斯置信传播神经网络(BCPNN)和经验贝叶斯几何均值(EBGM),来检测锂盐与各种不良事件之间的潜在信号。

结果

对美国食品药品监督管理局不良事件报告系统(FAERS)的6909份不良事件报告进行分析后发现,与锂盐相关的不良事件发生在内分泌、肾脏或泌尿系统、神经和精神系统。发现了一些众所周知的不良事件,如甲状腺功能减退、肾性尿崩症和共济失调。此外,还识别出了一些先前被忽视的不良事件,如肾嗜酸细胞瘤、甲状旁腺良性肿瘤和阿-斯综合征。

结论

通过分析真实世界的数据,本研究对锂盐的安全性概况进行了全面评估,为其临床风险提供了关键证据。然而,鉴于FAERS存在诸如轻微症状报告不足等固有局限性,应对研究结果谨慎解读。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad6/12215163/3399aa6d6cad/nps-2025-0000-0000-546602_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad6/12215163/3399aa6d6cad/nps-2025-0000-0000-546602_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aad6/12215163/3399aa6d6cad/nps-2025-0000-0000-546602_F01.jpg

相似文献

1
Safety Profile of Lithium: A Disproportionality Analysis Using the FDA Adverse Event Reporting System.锂的安全性概况:使用美国食品药品监督管理局不良事件报告系统的不成比例性分析
Neuropsychobiology. 2025 May 30:1-9. doi: 10.1159/000546602.
2
Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024.伊立替康的安全性评估:2004年至2024年期间使用FAERS和JADER数据库进行的真实世界不成比例性分析。
Front Pharmacol. 2025 Jun 9;16:1516449. doi: 10.3389/fphar.2025.1516449. eCollection 2025.
3
Characteristics of Adverse Events and Clinical Risks of Omaveloxolone Based on FAERS Data.基于FAERS数据的奥马伐醌不良事件特征及临床风险
Cerebellum. 2025 Jun 18;24(4):119. doi: 10.1007/s12311-025-01873-4.
4
Adverse drug reactions related to methotrexate: a real-world pharmacovigilance study using the FAERS database from 2004 to 2024.与甲氨蝶呤相关的药物不良反应:一项使用2004年至2024年FAERS数据库的真实世界药物警戒研究。
Front Immunol. 2025 Jun 4;16:1586361. doi: 10.3389/fimmu.2025.1586361. eCollection 2025.
5
Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database.揭示草酸艾司西酞普兰相关的潜在不良事件:基于 FDA 不良事件报告系统数据库的真实世界分析。
J Psychopharmacol. 2024 Jun;38(6):567-578. doi: 10.1177/02698811241249651. Epub 2024 Apr 27.
6
A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic.一项针对先前报道的天疱疮药物触发因素的全面、基于人群水平的评估突出了免疫调节能力这一共同特征。
Front Immunol. 2025 Jan 21;15:1508129. doi: 10.3389/fimmu.2024.1508129. eCollection 2024.
7
Gender and age disparities in cardiac immune-related adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database.免疫检查点抑制剂相关心脏免疫不良事件中的性别和年龄差异:FAERS数据库的药物警戒分析
BMJ Open. 2025 Jun 12;15(6):e090087. doi: 10.1136/bmjopen-2024-090087.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
The evolving role of disproportionality analysis in pharmacovigilance.药物警戒中比例失衡分析的作用演变。
Expert Opin Drug Saf. 2024 Aug;23(8):981-994. doi: 10.1080/14740338.2024.2368817. Epub 2024 Jun 24.
2
Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice.为什么锂盐不是双相情感障碍的首选药物?科学与临床实践之间的一场争论。 (注:原句中括号里的not根据语境判断不应有,否则语义不通顺,所以翻译时未保留)
Int J Bipolar Disord. 2024 Jan 16;12(1):3. doi: 10.1186/s40345-023-00322-7.
3
Lithium related thyroid and parathyroid disease: Updated clinical practice guidelines are needed.
锂相关的甲状腺和甲状旁腺疾病:需要更新临床实践指南。
J Affect Disord. 2023 Oct 15;339:471-477. doi: 10.1016/j.jad.2023.07.037. Epub 2023 Jul 11.
4
Clinicians' preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force.全球临床医生对锂盐用于双相情感障碍维持治疗的偏好与态度:国际双相障碍学会锂盐工作组的一项调查
Int J Bipolar Disord. 2023 May 27;11(1):20. doi: 10.1186/s40345-023-00301-y.
5
Long-Term Lithium Therapy: Side Effects and Interactions.长期锂盐治疗:副作用与相互作用
Pharmaceuticals (Basel). 2023 Jan 3;16(1):74. doi: 10.3390/ph16010074.
6
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper.为什么双相情感障碍患者应该使用锂盐?一项范围综述和一篇专家意见论文。
Expert Rev Neurother. 2022 Nov-Dec;22(11-12):923-934. doi: 10.1080/14737175.2022.2161895. Epub 2023 Jan 2.
7
Effect of lithium on circadian rhythm in bipolar disorder: A systematic review and meta-analysis.锂对双相情感障碍昼夜节律的影响:系统评价和荟萃分析。
Bipolar Disord. 2021 Aug;23(5):445-453. doi: 10.1111/bdi.13070. Epub 2021 Mar 16.
8
Bipolar disorders.双相情感障碍。
Lancet. 2020 Dec 5;396(10265):1841-1856. doi: 10.1016/S0140-6736(20)31544-0.
9
Make lithium great again!让锂元素再度大放异彩!
Bipolar Disord. 2020 Jun;22(4):325-327. doi: 10.1111/bdi.12942.
10
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.20 年来心境障碍在精神科医生门诊治疗中的药物治疗趋势。
Am J Psychiatry. 2020 Aug 1;177(8):706-715. doi: 10.1176/appi.ajp.2020.19091000. Epub 2020 Apr 21.